Chronic pain treatment: A high moral imperative with offsetting personal risks for the physician-a medical student's perspective

Pain Practice

Volumn 9, Issue 2, 2009, Pages 155-163

  Nathan, Jonathan I ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Medical education; Opioid prescribing; Opioid regulation; Opiophobia

Indexed keywords

ALFENTANIL; ANALGESIC AGENT; BUPRENORPHINE; BUTORPHANOL TARTRATE; CODEINE; DEXTROPROPOXYPHENE; DOVER POWDER; FENTANYL; FENTANYL CITRATE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROMORPHONE; LEVORPHANOL; METHADONE; MORPHINE SULFATE; MSCONTIN; NALBUPHINE; NORCO; OPIATE; OPIATE DERIVATIVE; OXYCODONE; PARACETAMOL; PENTAZOCINE; PERCOCET; PERCODAN; PETHIDINE; UNCLASSIFIED DRUG;

ACCREDITATION; ANALGESIA; ARTICLE; CANCER PAIN; CERTIFICATION; CHRONIC PAIN; CONTINUING EDUCATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG LEGISLATION; DRUG SAFETY; DRUG TOLERANCE; DRUG USE; EDUCATION PROGRAM; HEALTH BELIEF; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HELP SEEKING BEHAVIOR; HUMAN; LAW SUIT; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL PRACTICE; MEDICAL PRACTICE ACT; MEDICAL PROFESSION; MEDICAL SPECIALIST; MEDICAL STUDENT; MEDICOLEGAL ASPECT; MORALITY; OPIATE ADDICTION; PERSONAL EXPERIENCE; PHYSICAL DISEASE; PRACTICE GUIDELINE; PRESCRIPTION; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; PROFESSIONAL STANDARD; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; SYMPTOM; VITAL SIGN; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; CHRONIC DISEASE; EDUCATION, MEDICAL; HUMANS; MORAL OBLIGATIONS; PAIN; PHYSICIANS; RISK; STUDENTS, MEDICAL;

EID: 61549134727     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2008.00257.x     Document Type: Article

References (62)

1. SUPPORT Study Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients. JAMA. 1995;274:1591-1598.
2. Federation of State Medical Boards of the U.S. Inc. Model Policy for the Use of Controlled Substances for the Treatment of Pain. 2004. Available at: http://www.fsmb.org/pdf/2004_grpool_Controlled_Substances.pdf
3. The Joint Committee on Accreditation of Healthcare Organizations (JCAHO). Gallup Survey. Princeton, NJ: The Gallup Organization; 1999.
4. Brookoff D. Chronic pain: 1. A new disease. Hosp Pract. 2000;35:45-52,59.
5. Fox CD, Berger D, Fine PG, et al. Pain Assessment and Treatment in the Managed Care Environment. A Position Statement from the American Pain Society. Glenview, IL: American Pain Society; 2000.
6. The Joint Commission on Accreditation of Healthcare Organizations. Pain standards for 2001. 2001. Available at: http://www.jcaho.org/standards/ stds2001_mpfrm.html.
7. Day M. Pain medicine: A medical specialty? Pain Pract. 2004;4:1-10.
8. Paradise LA, Raj PP. Competency and certification of pain physicians. Pain Pract. 2004;4:235-244.
9. Pain: Current Understanding of Assessment, Management, and Treatments. June 2006. Online Continuing Education Pain Program offered by American Pain Society.
10. Loeser JD. Pain disease or dis-ease? The John Bonica lecture: Presented at the Third World Congress of World Institute of Pain, Barcelona 2004. Pain Pract. 2005;5:77-84.
11. Thernstrom M. Pain, the disease. The New York Times. 2001, Dec 16.
12. Niv D, Devor M. Chronic pain as a disease in its own right. Pain Pract. 2004;4:179-181.
13. Schim JD, Stang P. Overview of pain management. Pain Pract. 2004;4:S4-S18.
14. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349:1943-1953.
15. Marks RM, Sachar EJ. Undertreatment of medical inpatients with narcotic analgesics. Ann Int Med. 1973;78:173-181.
16. Ventafridda V, Saita L, Ripamonti C, De Conno F. WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React. 1985;7:93-96.
17. Burton AW, Cleeland CS. Cancer pain: Progress since the WHO guidelines. Pain Pract. 2001;1:236-242.
18. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 1987;59:850-856.
19. Jacox AK, Carr DB, Chapman CR, et al. Acute Pain Management: Operative or Medical Procedures and Trauma Clinical Practice Guideline No. 1. Rockville, MD: US Department of Health and Human Services, Agency for Health Care Policy and Research; 1992. AHCPR Archived Clinical Practice Guidelines.
20. The Use of Opioids for the Treatment of Chronic Pain. A consensus statement from American Academy of Pain Medicine and American Pain Society. 1996. Available at: http://www.ampainsoc.org/advocacy/ opioids.htm
21. Federation of State Medical Boards of the U.S. Inc. Model Guidelines for the Use of Controlled Substances for the Treatment of Pain. 1998. Available at: http://www.nsmadocs.org/pdf/ModelGuidelines.pdf
22. Fields HL. Should we be reluctant to prescribe opioids for chronic non-malignant pain? Pain. 2007;129:233-234. Epub 2007 Apr 20.
23. Forbes K. Opioids: Beliefs and myths. J Pain Palliat Care Pharmacother. 2006;20:33-35.
24. Morgan JP. American opiophobia: Customary underutilization of opioid analgesics. Adv Alcohol Subst Abuse. 1985;5:163-173.
25. Bennett DS, Carr DB. Opiophobia as a barrier to the treatment of pain. J Pain Palliat Care Pharmacother. 2002;16:105-109.
26. Rhodin A. The rise of opiophobia: Is history a barrier to prescribing? J Pain Palliat Care Pharmacother. 2006;20:31-32.
27. Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage. 1992;7:69-77.
28. Lema MJ. A compassionate approach to pain management in the terminally ill patient. Hosp Med. 1998;34:11-21.
29. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation (4th edition). 2007. Available at: http:// www.painpolicy.wisc.edu/
30. Richeimer SH. Opioids for pain: Risk management. Semin Anesth. 2005;24:165-169.
31. Mehendale AW, Patrick D, Goldman M. Managing chronic-pain patients in the new millennium: Clinical basis and regulatory viewpoint from Texas, U.S.A. Pain Pract. 2004;4:105-129.
32. Guidelines and Policy Statements. Texas Medical Board. 2006. Available at: http://www.tmb.state.tx.us/
33. Hill CS Jr. The barriers to adequate pain management with opioid analgesics. Semin Oncol. 1993;20(2 suppl 1):1-5.
34. Pain Management: A Handbook for Texas Physicians. 2006. Practice Management Distance Learning and Publications offered by Texas Medical Association.
35. Rosenblatt AB, Mekhail NA. Management of pain in addicted/illicit and legal substance abusing patients. Pain Pract. 2005;5:2-10.
36. Texas Medical Liability Trust 2007 Annual Report. Available at: http:// www.TMLT.org
37. Fishman SM. From balanced pain care to drug trafficking: The case of Dr. William Hurwitz and the DEA. Pain Med. 2005;6:162-164.
38. Tierney J. Trafficker or healer? And who's the victim? The New York Times. March 27, 2007.
39. Tierney J. A win for Dr. Hurwitz, a loss for the pill-counters. The New York Times. July 13, 2007.
40. Sullum J. Good cop, bad doctor. Reason.com. May 2, 2007.
41. Tierney J. Judge dismisses the most serious charges against Dr. Hurwitz. The New York Times. April 19, 2007.
42. Tierney J. Dr. Hurwitz convicted on 16 counts of drug trafficking. The New York Times. April 27, 2007.
43. Associated Press. Virginia: Doctor sentenced in drug case. The New York Times. July 14, 2007.
44. Hurwitz W. The challenge of prescription drug misuse: A review and commentary. Pain Med. 2005;6:152-161.
45. Gallagher RM. Opioids for intractable pain: The good, the bad and the ugly. Pain Med. 2005;6:103-104.
46. Ortolon K. Painful marks. Tex Med. 2006;102:31-35.
47. Issuance of Multiple Prescriptions for Schedule II Controlled Substances. Federal Register Rules and Regulations. 2007. Available at: http://www.deadiversion.usdoj.gov/fed_regs/rules/2007/fr1119.htm
48. Opioid Treatment Regulation. Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies, 2006. Available at: http://www.dpt.samhsa.gov/
49. Katzung BG. Basic and Clinical Pharmacology. 9th ed. New York: McGraw-Hill Companies, Inc.; 2004.
50. Manchikanti L. Prescription drug abuse: What is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources. Pain Physician. 2006;9:287-321.
51. Manchikanti L, Brown KR, Singh V. National All Schedules Prescription Electronic Reporting Act (NASPER): Balancing substance abuse and medical necessity. Pain Physician. 2002;5:294-319.
52. Howland RD, Mycek MJ. Lippincott's Illustrated Reviews: Pharmacology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
53. Manchikanti L, Whitfield E, Pallone F. Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): A public law for balancing treatment of pain and drug abuse and diversion. Pain Physician. 2005;8:335-347.
54. Manchikanti L. National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician. 2007;10:399-424.
55. Fukshansky M, Are M, Burton AW. The role of opioids in cancer pain management. Pain Pract. 2005;5:43-53. quiz 53-54.
56. Fishman SM, Kreis PG. The opioid contract. Clin J Pain. 2002;18(suppl):S70-5.
57. Fishman SM, Bandman TB, Edwards A, Borsook D. The opioid contract in the management of chronic pain. J Pain Symptom Manage. 1999;18:27-37.
58. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6:432-442.
59. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: A rational approach to the treatment of chronic pain. Pain Med. 2005;6:107-112.
60. Burton AW. The rational use of opioids in pain medicine. Texas Pain Symposium 2007. Texas Tech University Health Sciences Center, Lubbock, TX. 2007, July. Personal Communication.
61. Thomson P. Lessons of pain. New Physician. 2006;55:35-38.
62. Benedetti C. Pain: The magnitude of the problem and unmet therapeutic needs. Biomed Microdevices. 2001;3:125-132.